BRIDGETTE OBINKU: Open Payments
NPI 1396407631 · CLEBURNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 23 payments from 6 companies in 2025. Trend: 2023 $258 · 2024 $206 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $310 |
| Otsuka America Pharmaceutical, Inc. | 8 | $154 |
| Alkermes, Inc. | 4 | $95 |
| ABBVIE INC. | 3 | $77 |
| Lundbeck LLC | 2 | $59 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
Products named: CAPLYTA, REXULTI, ARISTADA, VRAYLAR, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
